3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Brain Neoplasms
1905
Glioblastoma
1797
Glioma
1130
Central Nervous System Neoplasms
599
Astrocytoma
594
Neuroblastoma
552
Gliosarcoma
465
Oligodendroglioma
364
Neoplasms
312
Breast Neoplasms
273
Medulloblastoma
272
Carcinoma, Non-Small-Cell Lung
227
Recurrence
199
Sarcoma
184
Neoplasm Metastasis
183
Melanoma
182
Meningioma
177
Ependymoma
176
Lung Neoplasms
157
Lymphoma
134
Osteosarcoma
127
Meningeal Carcinomatosis
126
Neurofibromatosis 1
114
Wilms Tumor
111
Ovarian Neoplasms
110
Diffuse Intrinsic Pontine Glioma
105
Precursor Cell Lymphoblastic Leukemia-Lymphoma
103
Rhabdomyosarcoma
101
Lymphoma, Non-Hodgkin
96
Burkitt Lymphoma
89
Interventions
Granulocyte-Macrophage Colony-Stimulating Factor
1
Diphtheria-Tetanus Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Xanthomatosis, Cerebrotendinous
×
CNS
×
Clear all
NCT03396575
2025-10-29
BRAVO
University of Florida
Phase 1
Terminated
11 enrolled